6th Annual International Breast Cancer Conference - Hall A - 18th Nov 2022
Welcome & Introduction
Molecular profiling in diffuse large B cell lymphomas
Role of autologous transplant and CART therapy for DLBCL
How I treat relapse refractory DLBCL
Novel & Targeted agents in Gastric Cancer
Pancreatic Cancer Newer Treatment options
Novel Agents & targets in HCC
Update on Management of Advanced Biliary Tract Cancer
Sequencing of therapies in te management of mCRPC
New age Management of Prostate Cancer a focus on PARP inhibitors
Selection of Rx for RCC Adjuvant & 1st line Rx in metastatic disease
2nd Line options in renal Cell cancer
First Line Immunotherapy in the management of RCC
Panel Discussion-metastatic RCC
Current Treatment Landscape in First line Urothelial Cancer
Overall survival at its core The new ABC (Avelumab in Bladder Cancer)
Panel Discussion-Management of Advance Bladder Cancer
Advances in Novel Formulations of Taxanes
Panel Discussion-Management of Prostate Cancer
Closing Remarks